ID
| SAD
| BIOLOGIC
| Sex
| Age
| Side effects
| Response
| Death
|
|---|---|---|---|---|---|---|---|
1 |
LES |
rituximab |
F |
49 |
No |
Yes |
No |
2 |
BEHÇET |
infliximab |
F |
30 |
No |
Yes |
No |
3 |
STILL ADULTO |
infliximab |
F |
45 |
Yes |
Yes |
No |
4 |
SJOGREN |
rituximab |
F |
79 |
No |
Yes |
No |
5 |
PAN |
infliximab |
M |
31 |
No |
No |
No |
6 |
SAF |
rituximab |
F |
51 |
No |
No |
No |
7 |
STILL ADULTO |
infliximab |
F |
43 |
No |
Yes |
No |
8 |
PAN |
infliximab |
F |
43 |
Yes |
Yes |
No |
9 |
VOGT-KOYANAGI |
infliximab |
F |
37 |
Yes |
No |
No |
10 |
PAM + SJOGREN + AR |
etanercept |
F |
69 |
No |
Yes |
No |
11 |
CRIOGLOBULINEMIA-VHC |
rituximab |
F |
58 |
No |
Yes |
Yes |
12 |
SJOGREN |
rituximab |
F |
82 |
Yes |
Yes |
No |
13 |
LES |
rituximab |
F |
32 |
No |
Yes |
No |
14 |
DERMATOMIOYesTIS |
infliximab |
M |
43 |
Yes |
No |
No |
15 |
DERMATOMIOYesTIS |
infliximab |
F |
59 |
Yes |
Yes |
No |
16 |
DERMATOMIOYesTIS |
etanercept |
F |
75 |
Yes |
Yes |
No |
17 |
LES |
rituximab |
F |
31 |
No |
Yes |
No |
18 |
LES |
rituximab |
F |
49 |
No |
No |
No |
19 |
WEGENER |
rituximab |
F |
59 |
Yes |
Yes |
No |
20 |
LES |
rituximab |
F |
42 |
Yes |
No |
No |
21 |
LES |
rituximab |
M |
23 |
No |
No |
No |
22 |
LES |
rituximab |
F |
28 |
No |
Yes |
No |
23 |
LES |
rituximab |
F |
19 |
No |
Yes |
No |
24 |
LES |
rituximab |
F |
24 |
No |
Still Pending |
No |
25 |
LES |
rituximab |
M |
24 |
No |
Yes |
No |
26 |
LES |
rituximab |
F |
46 |
No |
Yes |
No |
27 |
LES |
rituximab |
M |
38 |
No |
Yes |
No |
28 |
LES |
rituximab |
F |
35 |
No |
Yes |
No |
29 |
LES |
rituximab |
F |
22 |
No |
Yes |
No |
30 |
ESCLEROYesS YesSTEMICA |
rituximab |
F |
23 |
No |
Yes |
No |
31 |
WEGENER |
rituximab |
F |
28 |
No |
No |
No |
32 |
WEGENER |
rituximab |
M |
40 |
No |
No |
No |
33 |
WEGENER |
rituximab |
M |
48 |
No |
Yes |
Yes |
34 |
WEGENER |
rituximab |
M |
52 |
No |
Yes |
No |
35 |
BEHÇET |
infliximab |
F |
24 |
No |
No |
No |
36 |
BEHÇET |
infliximab |
F |
41 |
No |
Yes |
No |
37 |
LES |
rituximab |
F |
24 |
Yes |
Yes |
No |
38 |
STILL ADULTO |
infliximab |
F |
37 |
No |
Yes |
No |
39 |
WEGENER |
rituximab |
F |
35 |
No |
Yes |
No |
40 |
PAM |
rituximab |
M |
65 |
No |
Yes |
No |
41 |
DERMATOMIOYesTIS |
rituximab |
M |
40 |
No |
Yes |
No |
42 |
LES |
rituximab |
F |
39 |
No |
Yes |
No |
43 |
SAF |
rituximab |
F |
51 |
Yes |
Yes |
No |
44 |
CRIOGLOBULINEMIA-VHC |
rituximab |
F |
48 |
No |
Yes |
No |
45 |
LES |
rituximab |
F |
52 |
Yes |
No |
No |
46 |
LES |
rituximab |
F |
30 |
No |
Yes |
No |
47 |
LES |
rituximab |
M |
31 |
No |
Yes |
No |
48 |
BEHÇET |
infliximab |
M |
29 |
No |
Yes |
No |
49 |
BEHÇET |
infliximab |
M |
33 |
No |
Yes |
No |
50 |
LES |
rituximab |
F |
31 |
Yes |
Yes |
No |
51 |
LES |
rituximab |
M |
29 |
Yes |
Yes |
No |
52 |
SJOGREN |
rituximab |
M |
50 |
No |
Yes |
No |
53 |
LES |
rituximab |
F |
19 |
No |
Yes |
No |
54 |
SJOGREN |
rituximab |
F |
43 |
No |
Yes |
No |
55 |
SJOGREN |
rituximab |
F |
73 |
No |
Yes |
No |
56 |
SJOGREN |
rituximab |
F |
59 |
No |
Yes |
No |
57 |
LES |
rituximab |
M |
17 |
No |
Yes |
No |
58 |
BEHÇET |
infliximab |
M |
41 |
No |
No |
No |
59 |
DERMATOMIOYesTIS |
etanercept |
F |
53 |
No |
Still Pending |
No |
60 |
LES |
rituximab |
F |
31 |
No |
Yes |
No |
61 |
SJOGREN |
rituximab |
F |
28 |
No |
Yes |
no |
62 |
POLICONDRITIS |
infliximab |
F |
35 |
No |
No |
No |
63 |
DERMATOMIOSITIS |
rituximab |
F |
40 |
No |
No |
Si |
64 |
SJOGREN |
rituximab |
F |
57 |
No |
Si |
No |
65 |
SJOGREN |
rituximab |
F |
55 |
No |
Si |
No |
66 |
PAN |
rituximab |
F |
48 |
No |
Si |
Si |
67 |
SAF |
rituximab |
M |
43 |
No |
No |
No |
68 |
LES |
rituximab |
F |
34 |
No |
pdte |
No |
69 |
STILL ADULTO |
Etanercept |
M |
34 |
No |
No |
No |